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Case Report
CD4+ T lymphocytopenia associated with sideropenia:
case report
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ABSTRACT
Importance of the issue: Idiopathic CD4 T lymphocytopenia is an unusual immune defect in which
there is an unexplained deficit of CD4 T cells. This case presents a 39-year-old female patient, with
CD4+ T lymphocytopenia, who was not infected with immunosuppressive viruses neither was she sub-
jected to immunosuppressive therapies. Comments: While monitoring the patient, she was found to
have very low serum ferritin and, after parenteral iron therapy, there were changes in CD4+ cell levels,
indicating that, in this case, lymphocytopenia was secondary to sideropenia. The patient is being kept
under strict control of serum iron and periodic immunological evaluation, and she has not showed any
clinical and/or laboratory adverse events so far. It is known that iron deficiency is an important factor in
the genesis of immunological changes that occur in patients with iron deficiency anemia. It is important
to understand the effects of iron deficiency on the immune system due to its high prevalence worldwide.
Moreover, it could also help to clarify several cases of idiopathic CD4 lymphocytopenia.
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RESUMO
Importância da questão: Linfocitopenia T CD4+ idiopática é um defeito imune incomum em que há um
déficit inexplicável de células T CD4. Este caso clínico apresenta uma paciente do sexo feminino de 39
anos de idade, com linfocitopenia T CD4+, que não estava infectada por vírus imunossupressores nem foi
submetida a terapias imunossupressoras. Comentários: Durante o acompanhamento da paciente, ela
apresentou níveis muito baixos de ferritina sérica e, após a terapia parenteral de ferro, houve aumento da
quantidade de células CD4+, indicando que, neste caso, linfocitopenia era secundária à sideropenia. A
paciente estava sendo mantida sob rigoroso controle de ferro sérico e avaliação imunológica periódica, e
não mostrou quaisquer eventos adversos clínicos e/ou laboratoriais até o momento. Com base em mu-
danças na reatividade imunológica dos pacientes observadas por outros pesquisadores após a suplemen-
tação com ferro, é evidente que a deficiência de ferro seria um fator importante na gênese das alterações
imunológicas que ocorrem em pacientes com anemia ferropriva. É importante compreender os efeitos da
deficiência de ferro no sistema imune, devido à sua elevada prevalência mundial. Essas informações
também auxiliariam a esclarecer vários casos de linfocitopenia T CD4+ idiopática.
Palavras-chave: T-Linfocitopenia Idiopática CD4-Positiva. Deficiência de Ferro. Relatos de Casos.
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Introduction
Idiopathic CD4 lymphocytopenia (ICL) is a rare
syndrome characterized by the total CD4+ cell count
lower than 300 cells/µl, or lower than 20% of T lym-
phocytes, in adults. There is often no laboratory
evidence of infection by the human immunodefi-
ciency virus (HIV-1 or HIV-2) or by the human T-
lymphotropic virus (HTLV-1 or HTLV-2) in patients
with ICL, and there is absence of depression-re-
lated CD4+ T lymphocyte therapy.
Even though establishing the presence of lym-
phocytopenia in an HIV-uninfected patient with an
opportunistic infection is relatively straightforward,
determining whether the patient has ICL is not. The
differential diagnosis of ICL is broad1 so it is made
by exclusion and requires an extensive immunologic,
hematologic, rheumatologic and infectious disease
workup, as well as follow-up testing to confirm the
persistence of lymphocytopenia. As stated in the
syndrome definition, other forms of immunodefi-
ciency have to be excluded and the provisional ICL
diagnosis must be confirmed by a laboratory test at
least twice within 1 to 3 months. A comprehensive
immunologic workup must be performed in order
to exclude HIV infection, lymphoma, autoimmune
diseases, other forms of immunodeficiency (such
as common variable immunodeficiency), and sar-
coidosis.2
In cases without any immunosuppressive con-
ditions such as the aforementioned, it is difficult to
identify the causative agent of lymphocytopenia,
making the cure/permanent improvement of the
patient virtually impossible.
Case Report
BVS, a 39-year-old female patient, was ad-
mitted for the first time at the Hematology Outpa-
tient Care at the Clinic Hospital of Federal Univer-
sity of Triangulo Mineiro (HC/UFTM) in 2002. The
patient had leukopenia for two years, but had no
clinical signs and/or complications.
In the first evaluation, the patient weighed
47 kg, measured 1.71m in height, and had a BMI of
16.1 kg/m2. Hematological levels were as follows:
hemoglobin (Hb) was 11.6 g/dL, leukocytes were
3.0 x 109/L (1.8 x 109 neutrophils/L and 1.1 x 109
lymphocytes/L), and platelets were 109 x 109/L.
She did not present lymph node enlargement,
hepatosplenomegaly on physical examination.
The patient was monitored monthly with he-
matology controls, at first, and then semianually until
February 2008, with Hb ranging from 11 to 12.7 g/
dL, leukocytes ranging from 3.2 to 4.7 x 109/L (neu-
trophils between 1.9 and 3.4 x 109/L, and lympho-
cytes between 0.7 and 1.6 x 109/L). The patient in-
terrupted the follow-up, returning to the hospital only
in July 2011, referring pharyngitis, sinusitis and re-
current urinary infections, with increased levels of
IgM. She had been taking prophylactic nitrofuran-
toin and sulfa drugs for the last four months, and
these complications were controlled. On that occa-
sion, the patient’s hemoglobin was 11.9 g/dL and
leukocytes were 3.5 x 109/L (lymphocytes were 0.9
x 109/L), as follows: CD4+ T cell count was 90 cells/
µL, CD8+ T cell count was 119 cells/µL (CD4/CD8:
0.75), CD19+ cell count was 187 cells/µL, and CD56+
T cell count was 49 cells/µL. The other tests are
listed in Table 1.
Twenty days later, the patient was asymptom-
atic, with 13.8 g/dL hemoglobin, 5.9 x 109/L leuko-
cytes (1 x 109/L lymphocytes) and 232 x 109/L plate-
lets. The clinical examination was normal, despite
that fact that she had low body weight (46 kg, BMI:
15.7 kg/m²) and anorexia, with low food intake for
several years. After nutritional evaluation, the pa-
tient was subjected to a high calorie and high pro-
tein diet, and gained six kilos (52 kg, BMI: 17.8 kg/
m2). At this moment, hemoglobin level was 12.5 g/
dl, but ferritin level was 7.3 µg/L, and CD4+ and
CD8+ lymphocytes remained virtually unchanged
(Table 1).
During the evaluation period, aspiration and
biopsy of the bone marrow were performed and sig-
nificant changes in myelopoiesis were not observed
at any time.
Iron therapy was started, and four months
later the patient’s hemoglobin was 13.6 g/dL, fer-
ritin was 83.5 µg/L, and the levels of CD4+ and CD8+
T cells had been repaired (Table 1).
Discussion
Despite twenty years of research, ICL remains
a syndrome of uncertain pathogenesis, prognosis
and treatment. Although a subgroup of patients
remain asymptomatic, other patients may continue
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Table 1. Values of CD3, CD4, CD8, CD19, CD56 cell quantification, CD4/CD8 ratio, IgG, IgM and IgA immunoglobulins
and ferritin levels of patient, during her treatment period at the Clinic of Hematology of HC/UFTM.
02-22-05 04-06-11 07-08-11 12-12-11 04-17-12 06-22-12 Reference values
Phenotyping
CD3 - 336 cells/µL 210 cells/µL 302 cells/µL 1,009 cells/µL 887 cells/µL 1,000-3,900 cells/µL
(69.4%) (64.9%) (55%-82%)
CD4 - 161 cells/µL 90 cells/µL 118 cells/µL 569 cells/µL 459 cells/µL 359-1,725 cells/µL
(30.4%) (27.7%) (27%-57%)
CD8 - - 119 cells/µL 154 cells/µL 516 cells/µL 376 cells/µL 300-1,000 cells/µL
(36.7%) (14%-34%)
CD19 - - 187 cells/µL - - - 90-680 cells/µL
(12.7%) (6%-17%)
CD56 - - 5.2% - - - 75-500 cells/µL
(6%-29%)
CD4/CD8 - - 0.75 0.77 3.20 1.22 0.98-3.24
Immunoglobulins
IgG - 10.4 g/L - 10.7 g/L - 9.7 g/L 5.3-16.5 g/L
IgM - 7.7 g/L - 3.0 g/L - 2.5 g/L 0.5-2.0 g/L
IgA - 1.2 g/L - 1.4 g/L -  0.9 g/L 0.8-4.0 g/L
Ferritin 17.8 µg/L - - 7.3 µg/L 83.5 µg/L 30.5 µg/L 15.0 a 300 µg/L
Reference values: JAMA Instructions for Authors, 1997.
to develop fatal opportunistic infections3 or autoim-
mune diseases.4 Increased levels of IgM (> 3X the
normal range) were observed in the patient on 6th
April 2011. At this time, the patient had multiple
infectious complications, which probably led to in-
creased levels of this immunoglobulin. These val-
ues decreased to almost reach the limits of normal
levels (2.5 g/L) on 17th April 2012, when CD4 and
CD8 T cell levels were within normal limits and there
were no infectious complications.
The decrease in IgM levels from 7.7 to 3.0 g/L
in three months and to 2.5 g/L in twelve, the nor-
mal results found in bone marrow aspirations and
bone marrow biopsy and the absence of monoclonal
peak excluded the possibility of monoclonal gamm-
opathy and Waldenström Macroglobulinemia.
In 2005, the patient’s ferritin levels were near
the lower normal limits. Sideropenia was not inves-
tigated more thoroughly because, at that time, the
patient was asymptomatic, with only mild leukope-
nia, neutropenia and lymphocyte levels near the
lower normal limits. In 2011, when the patient had
infectious complications, assessment showed that
she had very low levels of serum ferritin. As the
patient denied gastrointestinal blood loss and hy-
permenorrhea, and the fecal occult blood test per-
formed before iron therapy was negative, we sus-
pected that sideropenia could be due to chronic
malnutrition.
The low and inadequate chronic intake of nu-
trients was responsible for malnutrition and ane-
mia of the patient, since, in both the nutritional
questioning carried out by the nutritionist and in
the clinical evaluations, the low consumption of car-
bohydrates, proteins and iron was documented.
However, it was also demonstrated by the persis-
tence of low ferritin levels after improvement of the
patient’s nutritional status that the iron intake was
not sufficient to correct their deficiency. As reported
in clinical consultations, the patient reported great
difficulties in eating foods rich in proteins such as
meats and eggs and intolerance to oral iron therapy,
which justifies the non-correction of ferritin levels.
The rapid correction of CD4+ and CD8+ T cell levels
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following the introduction of parenteral iron therapy
suggests that immunological deficiency was related
to iron deficiency, which in turn was caused by pro-
tein-calorie mineral malnutrition.
Tichelli et al. (1992) found that anemia is
accompanied by slight leukopenia in one third of
the patients, and platelet counts may be normal,
increased or decreased.5 After parenteral iron
therapy, CD3+, CD4+ and CD8+ T cells were found
to be improved, corroborating the hypothesis that,
in this case, lymphocytopenia was secondary to iron
deficiency. Chronic idiopathic neutropenia of adults
was also found in individuals with iron deficiency,
and the recovery or improvement of neutrophil count
was observed upon iron supplementation.6
It is known that iron is essential for the nor-
mal development of the immune system – it is an
important peroxide compound of nitric oxide gen-
erating enzymes, and it generates enzymes that are
critical to the proper enzymatic functioning of im-
mune cells.7
Santos and Falcão (1990) found immunologi-
cal abnormalities in patients with iron deficiency
anemia (IDA), which increased susceptibility to in-
fections.8 They evaluated subpopulations of lympho-
cytes in the peripheral blood of 21 patients with
IDA. The results showed that the average number
of total T cells (CD4+ and CD3+), as well as B lym-
phocyte subsets, were reduced in these patients
compared with control subjects.
In another study, significantly lower levels of
T lymphocytes, as well as CD4+ T cells, were found
in iron-deficient children in comparison with healthy
children.9 The CD4/CD8 ratio was found to be sig-
nificantly lower in the first group. In accordance with
these findings, there was a significant increase in
CD4+ T cells after oral iron supplementation. The
same was observed by Das et al. (2014) in a study
with 40 iron-deficient children and by Sejas et al.
(2008), who stated that IDA in children can signifi-
cantly affect circulating immature lymphocyte sub-
populations.10,11 They also observed that iron supple-
mentation significantly improved CD4+ T cell counts
and CD4:CD8 ratios.
A similar reduction in lymphocyte counts was
also observed in pre-menopausal women with IDA.
Lymphocyte subsets were studied in 50 adult pre-
menopausal women with iron deficiency anemia
(microcytic hypochromic anemia) and the results
were compared with healthy women. There were
significant differences in T cell counts, both in helper
T cells and cytotoxic T cells, between the case and
the control groups.12
Based on changes in immune reactivity of
patients observed after iron replacement, it is evi-
dent that iron deficiency is an important factor in
the genesis of immunological changes that occur in
patients with IDA. There are several possible mecha-
nisms that may explain the effects of iron deficiency
on the immune system. Neutrophils have a reduced
activity of myeloperoxidase, an iron-containing en-
zyme which produces reactive oxygen intermedi-
ates (ROI) that are responsible for intracellular kill-
ing of pathogens.13 In vitro studies have shown that
there is a direct correlation between iron deficiency
and impaired T-lymphocyte proliferation. There is a
decrease in T-lymphocyte blastogenesis and mito-
genesis in response to a number of different mito-
gens.7 Furthermore, iron deficiency induces atro-
phy of the thymus in laboratory animals and in hu-
mans, resulting in reduction of T cell proliferation
and/or differentiation.14
Iron deficiency is the most common known
form of nutritional deficiency in the world. It is a
major health problem in developed and developing
countries. Therefore, it is important to understand
the effects of this deficiency on the immune system
given its high prevalence. According to evidence in
the literature showing a close relationship between
iron and immune system functioning, we concluded
that this is a case of CD4 lymphopenia secondary to
sideropenia. The patient is being kept under strict
control of serum iron and periodic immunological
evaluation, and she has showed no clinical and/or
laboratory adverse events so far. Immunologists and
hematologists should work together to integrate this
type of information in order to resolve questions
such as those presented herein.
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